Search | IOVS | ARVO Journals

View

Showing 1 – 9 of 9

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2013

Morphological and functional outcomes of different pattern of diabetic macular oedema treated with 23gauge vitrectomy

Giancarlo Sborgia; Luisa Micelli Ferrari; Massimo Lorusso; Saba Ciani; Marco Leozappa; Tommaso Micelli Ferrari

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):2441. doi:

ARVO Annual Meeting Abstract March 2012

Features Of Inflammatory Choroidal Neovascular Membranes On Fluorescein Angiography And Optical Coherence Tomography

Giancarlo Sborgia; Pearse A. Keane; Michael Karampelas; Dawn A. Sim; John Chang; Adnan Tufail

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5196. doi:

ARVO Annual Meeting Abstract April 2010

PDT Low-Dose, Low-Fluence Rate for Chronic Central Serous Chorioretinopathy

F. Boscia; M. Reibaldi; G. Besozzi; N. Cardascia; C. Furino; S. Faro; M. Uva; G. Sborgia; A. Reibaldi; C. Sborgia

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):1348. doi:

ARVO Annual Meeting Abstract April 2010

Microperimetric Outcomes After 25-G Pars Plana Vitrectomy for Stage III/IV Macular Hole: A Prospective Study

G. Besozzi; F. Boscia; R. Provenzano; L. Sborgia; N. Recchimurzo; C. Furino; G. Sborgia; N. Cardascia; A. Montepara; C. Sborgia

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):2556. doi:

ARVO Annual Meeting Abstract April 2009

Minimal Vitrectomy for Epiretinal Membranes and Vitreomacular Traction Syndrome

F. Boscia; A. Milano; G. Sborgia; L. Sborgia; C. Furino; N. Cardascia

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):4208. doi:

ARVO Annual Meeting Abstract April 2009

Intravitreal Ranibizumab and Low Fluence Photodynamic Therapy to Treat Choroidal Neovascularization Due to Age-Related Macular Degeneration

G. Besozzi; F. Boscia; L. Sborgia; C. Furino; N. Cardascia; R. Dammacco; G. Sborgia; A. Ferrara; C. Sborgia

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):5223. doi:

ARVO Annual Meeting Abstract May 2008

Low Fluence Photodynamic Therapy in Chronic Central Serous Chorioretinopathy: Blind Randomised Clinical Trial of Efficacy and Safety

F. Boscia; M. Reibaldi; A. Longo; S. Faro; M. Uva; N. Cardascia; A. Russo; M. Sanfilippo; G. Sborgia; C. Furino

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):3278. doi:

ARVO Annual Meeting Abstract May 2008

Low Fluence Photodynamic Therapy to Treat Choroidal Neovascularization in Pathological Myopia: Efficacy and Safety

G. Besozzi; F. Boscia; L. Sborgia; C. Furino; N. Cardascia; R. Dammacco; A. Ferrara; G. Sborgia; A. Palma Modoni; C. Sborgia

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):283. doi:

ARVO Annual Meeting Abstract May 2007

Photodynamic Therapy With Low Fluence Pdt for Chronic Central Serous Chorioretinopathy: A Short Term Pilot Study

F. Boscia; N. Cardascia; C. Furino; R. Dammacco; G. Sborgia; M. Reibaldi

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):4151. doi:

Advertisement